{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:07:50Z","timestamp":1790111270503,"version":"4.0.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.3816\/cbc.2006.n.028","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T21:05:04Z","timestamp":1221080704000},"page":"164-166","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Long-Term Clinical Response in Leptomeningeal Metastases from Breast Cancer Treated with Capecitabine Monotherapy: A Case Report"],"prefix":"10.3816","volume":"7","author":[{"given":"Yee-Lu","family":"Tham","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Hinckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin S.","family":"Teh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Elledge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CBC.2006.n.028_bib1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1212\/WNL.55.1.117","article-title":"Response of leptomeningeal metastases from breast cancer to hormonal therapy","volume":"55","author":"Boogerd","year":"2000","journal-title":"Neurology"},{"key":"10.3816\/CBC.2006.n.028_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/1097-0142(197807)42:1<283::AID-CNCR2820420142>3.0.CO;2-#","article-title":"Meningeal carcinomatosis in breast cancer","volume":"42","author":"Yap","year":"1978","journal-title":"Cancer"},{"key":"10.3816\/CBC.2006.n.028_bib3","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/1097-0142(19820215)49:4<759::AID-CNCR2820490427>3.0.CO;2-7","article-title":"Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients","volume":"49","author":"Wasserstrom","year":"1982","journal-title":"Cancer"},{"key":"10.3816\/CBC.2006.n.028_bib4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1054\/bjoc.2000.1574","article-title":"Intrathecal treatment of neoplastic meningitis due to breast cancer with a slow-release formulation of cytarabine","volume":"84","author":"Jaeckle","year":"2001","journal-title":"Br J Cancer"},{"key":"10.3816\/CBC.2006.n.028_bib5","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/jjco\/hyg046","article-title":"Durable remission of leptomeningeal metastasis of breast cancer with letrozole: a case report and implications of biomarkers on treatment selection","volume":"33","author":"Ozdogan","year":"2003","journal-title":"Jpn J Clin Oncol"},{"key":"10.3816\/CBC.2006.n.028_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/00000421-200108000-00026","article-title":"Capecitabine for 5-fluorouracilresistant brain metastases from breast cancer","volume":"24","author":"Wang","year":"2001","journal-title":"Am J Clin Oncol"},{"key":"10.3816\/CBC.2006.n.028_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1215\/S1152851703000334","article-title":"Durable response of breast cancer leptomeningeal metastasis to capecitabine monotherapy","volume":"6","author":"Rogers","year":"2004","journal-title":"Neuro-oncol"},{"key":"10.3816\/CBC.2006.n.028_bib8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1023\/B:NEON.0000003752.89814.ca","article-title":"Response of neoplastic meningitis from solid tumors to oral capecitabine","volume":"65","author":"Giglio","year":"2003","journal-title":"J Neurooncol"},{"key":"10.3816\/CBC.2006.n.028_bib9","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1023\/A:1012281104865","article-title":"Randomized, openlabel, phase II trial of oral capecitabine (Xeloda) vs. a reference arm of intravenous CMF (cyclophosphamide, methotrexate and 5-fluorouracil) as first-line therapy for advanced\/metastatic breast cancer","volume":"12","author":"Oshaughnessy","year":"2001","journal-title":"Ann Oncol"},{"key":"10.3816\/CBC.2006.n.028_bib10","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1200\/JCO.1999.17.2.485","article-title":"Multicenter phase II study of capecitabine in paclitaxel-refractory metastatic breast cancer","volume":"17","author":"Blum","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.3816\/CBC.2006.n.028_bib11","series-title":"AHFS Drug Information","first-page":"916","article-title":"Capecitabine","author":"McEvoy","year":"2002"},{"key":"10.3816\/CBC.2006.n.028_bib12","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0360-3016(02)02856-0","article-title":"Preoperative chemoradiation using oral capecitabine in locally advanced rectal cancer","volume":"54","author":"Kim","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.3816\/CBC.2006.n.028_bib13","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1177\/030089160308900403","article-title":"Radiotherapy and oral capecitabine in the preoperative treatment of patients with rectal cancer: rationale, preliminary results and perspectives","volume":"89","author":"Corvo","year":"2003","journal-title":"Tumori"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911708916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820911708916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:11:57Z","timestamp":1761513117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820911708916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S1526820911708916"],"URL":"https:\/\/doi.org\/10.3816\/cbc.2006.n.028","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-Term Clinical Response in Leptomeningeal Metastases from Breast Cancer Treated with Capecitabine Monotherapy: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.3816\/CBC.2006.n.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}